GlassScriptPhysician profile
Frank A Buttacavoli
NPI 1487882346
$865,807.46
in general payments reported to CMS, 2019-2025
37 companies · $214K in 2025
The $214K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $2,348 · 2021: $58K · 2022: $167K · 2023: $206K · 2024: $176K · 2025: $214K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $195K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $169K · Consulting Fee: $160K · Travel and Lodging: $56K · Food and Beverage: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $195,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $168,548.13 |
| Consulting Fee | $159,999.77 |
| Travel and Lodging | $55,931.82 |
| Food and Beverage | $16,166.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $509,432.19 | 2019-2025 | Avenir, G7, Arcos |
| Kci USA, INC. | $152,708.16 | 2019-2023 | Prevena, V.A.C. Veraflo, Prevena Restor Arthroform |
| Sanara Medtech INC. | $86,615.50 | 2021-2025 | Celleraterx, Celleraterx, Biasurge |
| Solventum Corporation | $65,802.38 | 2024-2025 | Prevena, Prevena Restor Arthroform, Ioban 2 |
| Medtronic, INC. | $36,577.98 | 2021-2023 | Aquamantys(Tm) |
| Heraeus Medical, LLC. | $5,838.02 | 2020-2024 | Palacos |
| Restor3d, INC. | $2,058.40 | 2024-2025 | |
| Imbed Biosciences INC. | $1,189.54 | 2023 | |
| Stryker Corporation | $1,034.49 | 2019-2025 | Mako, T2, Variax |
| Davol INC. | $498.50 | 2020-2024 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $361.24 | 2019-2025 | Evos |
| Orthalign INC | $334.21 | 2022-2024 | Orthalign Plus |
| Bioventus LLC | $297.92 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Bone Support INC. | $287.55 | 2021-2025 | Cerament G, Ceramentbone Void Filler |
| Wishbone Medical INC. | $232.60 | 2021-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $228.09 | 2022-2023 | Zynrelef |
| Medela LLC | $219.64 | 2019 | |
| Depuy Synthes Sales INC. | $185.75 | 2019-2023 | Na |
| Kerecis Limited | $169.55 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Encore Medical, LP | $166.61 | 2025 | |
| Si-Bone, INC. | $160.31 | 2025 | |
| Globus Medical, INC. | $149.59 | 2022 | |
| Conformis, INC. | $132.86 | 2019 | |
| Vericel Corporation | $121.91 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $118.53 | 2020-2025 | Exparel |
| Ethicon US, LLC | $116.70 | 2021 | |
| Axogen | $116.58 | 2021 | |
| Baxter Healthcare | $114.74 | 2022 | |
| Medartis INC. | $104.43 | 2023 | Aptus |
| Pacira Therapeutics, INC. | $103.47 | 2021 | |
| Acumed LLC | $97.46 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $92.99 | 2025 | |
| Medtronic USA, INC. | $83.84 | 2019 | |
| Acera Surgical, INC. | $15.61 | 2023 | Restrata Wound Matrix |
| Ermi LLC | $14.90 | 2023 | |
| Ferring Pharmaceuticals INC. | $13.38 | 2024 | Euflexxa |
| Integra Lifesciences Corporation | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Buttacavoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.